Results Increased release of AIM from IgM pentamer during advanced CKD We revealed an increasing trend in the dissociation of AIM from IgM with the progression of CKD in severity, by analyzing the sera of 423 patients at the time of dialysis initiation (DI), 563 CKD patients across various GFR categories [G1-G2, G3a-G3b, and G4-G5] 31 , 32 , and 74 healthy controls without renal disease (HC).
← all excerpts
Release of apoptosis inhibitor of macrophage (AIM) from pentameric IgM in serum predicts prognosis after hemodialysis initiation.
1
—
—